Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed Aug 9, 2021 · 10-Q · 40 days after period end · 0001728117-21-000087
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Net Income | -$59.83M | -$66.87M | -$44.50M | -$32.73M |
| EPS Diluted | -$0.80 | -$1.00 | -$0.74 | -$5.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 9, 2021 · 40 d after period end
